Our free daily oncology focused e-news service.

Featured Oncology News

Cancer Can Bankrupt Its Victims. Obamacare Was Designed to Stop That.

(VOX) Feb 23, 2017 - Cancer is hugely expensive to treat. Obamacare provided some protection for patients against those costs. Millions are now in jeopardy under Obamacare repeal-and-replace plans.

read article

Advice From Patients On A Study's Design Makes For Better Science

(NPR/Shots blog) Feb 24, 2017 - Many studies designed to try out new drugs simply languish. They don't attract enough patients, and they aren't completed. Here's a story of one study that bucked that trend.

read article

Novartis Wins CHMP Nod for Drug Combo Against Some Lung Cancers

(Reuters) Feb 24, 2017 - Swiss drugmaker Novartis's drugs Tafinlar and Mekinist edged closer to approval in Europe to be used together against a type of lung cancer after a key committee on Friday published a recommendation to expand the combination's indications.

read article

Oncology Clinical News

First Look: Lab-grown Voice Boxes Aim To Offer A New Option For Larynx Cancer Patients

(STAT Plus) Feb 23, 2017 - It’s estimated that more than 13,000 new cases of laryngeal cancer will be diagnosed this year — some of which will cost patients all or part of the voice boxes — but new research using stem cells aims to save their speech by growing new larynges right in the lab.

read article (paid subscription required)

Discovery of Distinct Cell Subtypes Around Tumors Helps Explain Why Pancreatic Cancer Is So Hard to Treat

(Cold Spring Harbor Laboratory) Feb 23, 2017 - Distinct cellular subtypes in dense tumor-enveloping stroma may be precisely targeted to improve treatment response.

read press release

Study Reveals PGK1 Enzyme as Therapeutic Target for Deadliest Brain Cancer

(MD Anderson) Feb 23, 2017 - Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.

read press release

Tocagen Achieves Key Development Milestone for Lead Product: Phase 2 Randomized Trial in Patients with Recurrent Brain Cancer Fully Enrolled

(The Business Journals) Feb 23, 2017 - Top-line results anticipated 1H 2018.

read article

MabVax Therapeutics Announces FDA Authorization to Proceed with MVT-1075 in a Phase I Clinical Trial for the Treatment of Pancreatic Cancer

(Yahoo! Finance) Feb 23, 2017 - MabVax Therapeutics Holdings, Inc. announces that it has received notice from the U.S. Food and Drug Administration (FDA) authorizing the initiation a Phase I clinical trial with MVT-1075 as a therapeutic treatment for pancreatic cancer. MVT-1075 (177Lu-CHX-A″-DTPA-HuMab5B1) is the Company's novel fully human antibody radioimmunotherapy (RIT).

read article

Oncology Business and Policy News

REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma After Autologous Stem Cell Transplantation

(Celgene) Feb 24, 2017 - Oral REVLIMID® is the first and only medicine licensed in Europe for use as post-autologous stem cell transplantation maintenance therapy in multiple myeloma; the new indication expands the availability of REVLIMID® across the disease continuum of multiple myeloma.

read corporate press release

CHMP Issues Positive Opinion Recommending DARZALEX® (daratumumab) for Relapsed or Refractory Multiple Myeloma

(Morningstar) Feb 24, 2017 - CHMP issued positive opinion for DARZALEX for relapsed or refractory multiple myeloma; final decision from European Commission expected in the coming months; opinion based on data from two Phase III studies, CASTOR and POLLUX.

read article

Cancer Patients Could Be Disadvantaged by Brexit, Say Experts

(The Guardian [UK]) Feb 24, 2017 - British cancer patients could be left “significantly disadvantaged” by the UK’s departure from the EU, leading oncologists have said, as collaboration with European scientists has been vital to making breakthroughs in the field.

read article

ASCO Launches its New Journal Dedicated to Informatics

(ASCO in Action) Feb 23, 2017 - On February 23, 2017, ASCO launched its newest online-only journal, JCO Clinical Cancer Informatics (JCO CCI).

read article

Opinion: Cancer Treatment Is Changing and Coverage Must Change With It

(The Hill) Feb 23, 2017 - As recently as a decade ago, patients with advanced tumors would come to my office and I could offer little in either treatment or hope. Now I greet patients knowing that, for some, new approaches to fighting cancer may present something close to a cure.

read article

First Opinion: The Power — And The Fear — Of Knowing Your Cancer Genome

(STAT Plus) Feb 23, 2017 - When it comes to cancer, all knowledge is power — even when that knowledge is scary. Knowing as much as you can about cancer lets you and your health care team act decisively in devising your treatment strategy.

read article (paid subscription required)

CancerConnect Launches Online Community for Patients with Neuroendocrine Tumors

(CancerConnect.com) Feb 23, 2017 - OMNI Health Media (OMNI) announces the launch of a new online community on CancerConnect for individuals with neuroendocrine tumors (NET). This community will provide patients and their loved ones with information and support.

read corporate press release

Cancer Care Can Cost More Than Your Annual Salary

(WBMA-TV/ABC [Birmingham, AL]) Feb 23, 2017 - The cost of cancer care is exploding. Doctors say it will continue to be a problem for the next decade or two. Dr. Ed Partridge, the Director of UAB's Comprehensive Cancer Center says a significant amount of bankruptcies are related to cancer care.

read article

Broader Healthcare and Pharma News

Top Pharma Lobbyist Pledges To Be ‘Opportunistic’ Pushing Value-Based Reforms

(STAT Plus) Feb 23, 2017 - The drug industry is going all-in on its push to shift the conversation about drug prices to one about value, and its top lobbyist said the industry would be opportunistic in the coming months in finding legislative and administrative avenues to advance policies in pursuit of that goal.

read article (paid subscription required)

Big Pharma Quietly Enlists Leading Professors to Justify $1,000-Per-Day Drugs

(ProPublica) Feb 23, 2017 - As it readies for battle with President Trump over drug prices, the pharmaceutical industry is deploying economists and health care experts from the nation’s top universities. In scholarly articles, blogs and conferences, they lend their prestige to the lobbying blitz, without always disclosing their corporate ties.

read article

Cannabis Industry Roiled By White House Comments On Enforcement

(USA Today) Feb 23, 2017 - The White House threw the country’s marijuana industry into a panic after announcing Thursday that there would likely be “greater enforcement” of federal anti-cannabis laws under President Trump.

read article